Leerink Swann Hires Bill Suddath as Managing Director

The Boston-based healthcare investment bank Leerink Swann has brought aboard Bill Suddath as a managing director. Suddath will establish and lead the firm’s healthcare IT and technology-enabled services franchise. Suddath joins Leerink Swann from Robert W. Baird & Co., where he was a managing director.


Healthcare investment bank Leerink Swann announced that Bill Suddath has joined the Firm’s Investment Banking Team as Managing Director. Mr. Suddath will establish and lead the firm’s Healthcare IT and Technology Enabled Services franchise.

Over an 18-year career, Mr. Suddath has established himself as a leading M&A and Financing advisor to Healthcare IT, Revenue Cycle Management and Clinical Outsourcing services businesses targeting hospitals, providers, payers and businesses in the pharmaceutical and medical device supply chain. Mr. Suddath’s recent transaction experience includes advising 1) Medical Present Value on the $185 million sale to Experian, 2) Chamberlin Edmonds on the $260 million sale to Emdeon, 3) SterilMed on the recapitalization with Great Hill Partners and Primus Capital Funds and 4) Remedi SeniorCare on the recapitalization with Centerbridge Partners, L.P., among other completed transactions.

“I look forward to partnering with Bill to establish Leerink Swann as the pre-eminent advisor to Healthcare IT and Specialty Healthcare Services companies,” said James Boylan, Senior Managing Director and Head of Investment Banking at Leerink Swann. “In bringing Bill to Leerink, we are executing on our strategy of establishing Leerink Swann as the leading advisor to all healthcare companies across sectors that are focused on growth and innovation. Leerink Swann differentiates with strong domain knowledge and highly experienced bankers focused on middle market transactions, which is an excellent fit for Bill.”

“We founded the firm in 1995 with a focus on differentiated biopharmaceutical research and substantive institutional sales and trading relationships”, said Jeff Leerink, Chairman and Chief Executive Officer of Leerink Swann. “In 2009, we hired a world class investment banking team and have transformed the firm into a leading underwriter and M&A advisor to life sciences and medical technology companies. I am thrilled with the addition of Bill Suddath, who will expand our franchise and leadership position to include Healthcare IT and Specialty Healthcare Services. Bill brings a strategic M&A focus, an established franchise and relationships with corporate, private equity and venture capital investors that will meaningfully accelerate our leadership position in healthcare services.”

“With a dedicated focus on healthcare, differentiated research-driven model and the investments that the firm has made in personnel over the last several years, Leerink Swann has clearly established itself as a leader in healthcare investment banking,” said Mr. Suddath. “The Leerink platform offers an unparalleled combination of healthcare knowledge resources, extensive and trusted client relationships and execution excellence that will differentiate our Healthcare IT and Specialty Healthcare Services capabilities.”

Prior to joining Leerink Swann, Mr. Suddath was Head of Healthcare Services Investment Banking at Robert W. Baird, & Co. Previously, he spent the majority of his career serving healthcare and technology clients at Hambrecht & Quist (H&Q) and subsequently JPMorgan through their acquisition of H&Q.

Mr. Suddath holds a B.S. in Business Administration from Georgetown University.

Mr. Suddath will open the Leerink Swann office in Atlanta.

About Leerink Swann

Founded in 1995, Leerink Swann is recognized as a leading healthcare investment bank to a broad range of institutional, life sciences, corporate and high-net-worth clients that are positioned to shape the future of healthcare. Leerink Swann’s deep domain knowledge provides its clients thoroughly researched insights and perspectives that enable them to make well-informed investment and business decisions. All of its services are enhanced by the expertise of its proprietary MEDACorp network. MEDACorp’s 35,000+ physicians, researchers and healthcare professionals provide unparalleled insights into cutting-edge advances in healthcare. Guided by expert strategy and insight, we offer investment banking, merger and acquisition services, institutional sales and trading, equity research, consulting, and wealth management. Leerink Swann is a member of FINRA/SIPC. For more information, visit www.leerink.com .